Genomic DNA hypomethylation has been associated with colorectal carcinogenesis. Methionine synthase A2756G (MTR A2756G) is a common nonsynonymous polymorphism in the gene that encodes methionine synthase, a key enzyme in the pathway leading to DNA methylation. Several studies, but not all, have reported relatively lower plasma homocysteine among individuals with the AG or GG genotype. Meanwhile, higher plasma homocysteine was associated with genomic DNA hypomethylation in healthy volunteers. We therefore hypothesized that minor allele carriers possess a decreased risk of colorectal adenoma, and examined this hypothesis in a case-control study of colorectal adenoma in Japan involving 723 cases and 670 controls. An unconditional logistic regression model was used to estimate odds ratios (OR) and their 95% confidence intervals (95% CI) for colorectal adenoma after adjustment for potential confounders. Despite the lack of an overall association, we observed a significant interaction between MTR A2756G and alcohol intake (P for interaction = 0.007). Compared with never drinkers with the AA genotype, never drinkers with the AG or GG genotype exhibited a significantly decreased risk (OR, 0.56; 95% CI, 0.34-0.90) whereas heavy drinkers with the same genotypes showed a substantially increased risk (OR, 1.90; 95% CI, 1.04-3.46). In addition, a marginally significant interaction was observed with folate intake (P for interaction = 0.07). The G allele may confer protection against colorectal adenoma in the presence of a considerably good folate status. Our findings add to increasing evidence that DNA methylation plays an important role even at an early stage of colorectal carcinogenesis. (Cancer Epidemiol Biomarkers Prev 2009;18(1):267 -74) 
Introduction
Accumulating evidence indicates that DNA methylation plays an important role in colorectal carcinogenesis (1) . Aberrations in DNA methylation can affect the expression of proto-oncogenes and tumor suppressor genes involved in colorectal tumorigenesis (1) . DNA hypomethylation has been observed not only in colorectal neoplasm (2, 3) but also in normal-appearing colorectal mucosa from individuals with colorectal tumors (4) , suggesting that alterations in DNA methylation may occur even at an early stage of colorectal carcinogenesis.
Methionine synthase is a key enzyme in the pathway leading to DNA methylation, which catalyzes the remethylation of homocysteine to methionine. Methionine is the precursor of S-adenosylmethionine, the universal methyl group donor, which provides a methyl group to over 100 reactions, including DNA methylation. Methionine synthase is inactivated by the oxidation of vitamin B 12 , its essential cofactor, and reactivated by methionine synthase reductase, which catalyzes the reductive remethylation of vitamin B 12 .
Folate metabolism is profoundly implicated in the DNA methylation pathway. Folate is required in the form of 5-methyl-tetrahydrofolate for the remethylation of homocysteine, and its depletion results in genomic DNA hypomethylation (5) . In this folate metabolism, vitamins B 2 and B 6 work as crucial cofactors for methylenetetrahydrofolate reductase (MTHFR) and serine hydroxymethyltransferase, respectively. MTHFR regulates the synthesis of 5-methyl-tetrahydrofolate by catalyzing the irreversible conversion from 5,10-methylene-tetrahydrofolate to 5-methyl-tetrahydrofolate. Importantly, alcohol consumption interferes with folate metabolism (6) , and decreases the levels of serum folate (7), of which 5-methyl-tetrahydrofolate is the predominant component.
Methionine synthase A2756G (MTR A2756G, abbreviation set by consensus) is a common nonsynonymous polymorphism in the gene encoding methionine synthase. Although the functional effect of this polymorphism on methionine synthase has not been established, several studies have shown a relatively lower concentration of plasma homocysteine among individuals with the AG or GG genotype (8) (9) (10) (11) (12) . Meanwhile, an increase in plasma homocysteine was associated with genomic DNA hypomethylation in healthy female volunteers (13) , and relatively higher concentrations of serum homocysteine were observed among those with colorectal cancer (14) and adenomatous polyps (15) . We therefore hypothesized that minor allele carriers have a decreased risk of colorectal adenoma. Of several studies examining the association of MTR A2756G with colorectal cancer (16) (17) (18) (19) (20) (21) (22) , however, results have been equivocal. Further, fewer studies have investigated colorectal adenoma (4, (23) (24) (25) , although alterations in DNA methylation may influence the early stage of colorectal carcinogenesis.
Here, we examined this hypothesis in a case-control study of colorectal adenoma in a Japanese population by investigating the influence of MTR A2756G on the risk of colorectal adenoma, either alone or in interaction with dietary factors (folate; vitamins B 2 , B 6 , and B 12 ; and alcohol) or with other functional polymorphisms [MTHFR C677T and A1298C, and methionine synthase reductase A66G (MTRR A66G, abbreviation set by consensus)]. We selected these dietary factors and genetic polymorphisms because of their implication in the DNA methylation pathway, with MTHFR C677T and A1298C related to the enzymatic activity of MTHFR (26, 27) , and MTRR A66G to the affinity of methionine synthase reductase to methionine synthase (28) .
Materials and Methods
Study Population. The Colorectal Adenoma Study in Tokyo (CAST) was primarily designed to investigate gene-environment and gene-gene interactions in the risk of colorectal adenoma. Sample size was determined to allow the detection of an interaction odds ratio (OR) of z2-fold using a statistical test at the 5% significance level with 80% power. Study subjects consisted of examinees who underwent magnifying colonoscopy with dye spraying (29) (30, 31) . All examinees gave written informed consent to allow their data and materials collected through the screening program to be used for the purpose of medical research. The study protocol was approved by the institutional review board of the National Cancer Center, Tokyo, Japan.
Eligible examinees were men ages 50 to 79 y or women ages 40 to 79 y who underwent total colonoscopy from the anus to the cecum. Those with a history of the following diseases and conditions were considered ineligible: colorectal adenoma, malignant neoplasm, ulcerative colitis, Crohn's disease, familial adenomatous polyposis, carcinoid tumor, and colectomy. In a consecutive series of 3,212 examinees, 2,234 met the necessary conditions above. According to the pit-pattern classification (32), 526 men and 256 women were determined to have at least one adenoma and were thus included as cases. Of the remaining 1,452 examinees, 482 men and 721 women were also free from other benign lesions (e.g., hyperplastic polyps, inflammatory polyps, and diverticula) and were identified as potential controls. For efficiency, 256 women in the potential controls were frequency-matched to the female cases in five age categories (ages 40-49, 50-54, 55-59, 60-64, and z65 y) and screening periods (first and second halves). Because there were fewer potential male controls than male cases, all men in the potential controls were included in the study. Finally, the study enrolled 782 cases and 738 controls.
Blood Collection and Genotyping. Examinees were scheduled for blood collection 1 d before colonoscopic screening, at which fasting venous blood was drawn into a vacutainer tube with EDTA. The blood sample was centrifuged to obtain blood plasma and buffy coat, the latter of which was further purified into a pellet of WBC. These specimens were preserved at À80jC until analysis.
Genomic DNA was extracted from WBC using a FlexiGene DNA Kit (Qiagen). The TaqMan SNP Genotyping Assays (Applied Biosystems) were used for genotyping MTR A2756G [dbSNP ID: rs1805087, assay developed by Assays-by-Design as follows: forward PCR primer GGATGAATACTTTGAGGAAATCATG-GAAGA, reverse PCR primer TGTTTCTACCACT-TACCTTGAGAGACT, A allele reporter (dye: VIC) ATTAGACAGG(A)CCATTATG, and G allele reporter (dye: FAM) ACAGG(G)CCATTATG], MTRR A66G (dbSNP ID: rs1801394, Assay ID: C___3068176_10), MTHFR C677T (dbSNP ID: rs1801133, Assay ID: C___1202883_20), and MTHFR A1298C (dbSNP ID: rs1801131, Assay ID: C____850486_20). Genotyping was carried out with case and control status unknown. For the primary check of genotyping, we undertook a careful inspection of genotype scatter data from the 7900HT Sequence Detection System software, version 2.0 (Applied Biosystems). Deviation from the Hardy-Weinberg equilibrium was also checked. All four single nucleotide polymorphisms analyzed in this study passed these initial checks.
Of the CAST subjects, 1,406 (732 cases, 674 controls) had WBC specimens available for genotyping, with no statistical difference in availability between cases and controls. We could not genotype five cases and one control for MTR A2756G due to technical problems. With regard to the other polymorphisms, the number of subjects without genotyping information was 1 for MTRR A66G, 18 for MTHFR C677T, and 18 for MTHFR A1298C.
Self-administered Questionnaire. Before undergoing the screening program, examinees completed a selfadministered questionnaire concerning lifestyle characteristics and medical history. The composition of the questionnaire has been detailed elsewhere (31) .
The self-administered questionnaire included a food frequency questionnaire of 145 food and beverage items with standard portions/units and 9 frequency categories. Dietary intake of folate and vitamin Bs was also estimated from the responses, with reference to the Standard Tables of Food Composition in Japan, Fifth Revised Edition (33) . The food frequency questionnaire of the present study was essentially the same as that used in a prospective study among a Japanese population whose validity and reproducibility were established previously (34, 35) .
The food frequency questionnaire also included an inquiry about alcohol consumption. Drinking status was first inquired about with the three choices of current, past, and never. For current drinkers, the amount of alcohol consumed per week was calculated on the basis of the frequency of alcohol drinking and number of standard units consumed per occasion for five different alcoholic beverages (sake, shochu/awamori, beer, whisky, and wine). We have detailed the method by which ethanol intake is calculated from the food frequency questionnaire elsewhere (36) . Current drinkers were divided into three categories in proportion to their ethanol consumption (V150, 151-300, and >300 g/wk).
Statistical Analysis. ORs and their 95% confidence intervals (95% CI) of colorectal adenoma for MTR A2756G, other genetic polymorphisms (MTHFR C677T and A1298C, and MTRR A66G), and several dietary factors (alcohol, folate, and vitamins B 2 , B 6 , and B 12 ) were estimated using an unconditional logistic regression model. The first analysis controlled for sex and matching variables. In the next analysis, further adjustment was made for the following covariates: cigarette smoking (never, V20, 21-40, and >40 pack-years), alcohol consumption (never, past, <150, 150-299, z300 g/wk), body mass index (<21.0, 21.0-22.9, 23.0-24.9, z25.0 kg/m 2 ), family history of colorectal cancer (yes or no), and nonsteroidal anti-inflammatory drug use (yes or no). These covariates were suggested as potential confounders in a previous report from the CAST (31). Of 1,400 subjects genotyped for MTR A2756G, 7 had missing information for the covariates (tobacco smoking, 3; body mass index, 4) and were excluded from the current analysis. Nutrient consumption was energy-adjusted using the residual method (37) and divided into tertiles, the cutoff points of which were derived from the distribution among the whole controls.
We also examined whether MTR A2756G interacted with several dietary factors in the risk of colorectal adenoma. In the following analyses, we combined the MTR 2756 AG and GG genotypes. In prior studies, lower concentrations of plasma homocysteine were observed among those with the AG or GG genotype than among those with the AA genotype (8) (9) (10) (11) (12) , implying similar enzymatic activity of methionine synthase for the AG and GG genotypes. We obtained ORs and their 95% CIs of colorectal adenoma for each combination of MTR A2756G genotype and intake category for the respective dietary factors, with reference to the combination of the AA genotype and the lowest intake category. Similarly, gene-gene interactions were examined between MTR A2756G and selected polymorphisms, with individuals homozygous for the major alleles of the two polymorphisms used as the reference group. Finally, we statistically evaluated these interactions based on the likelihood ratio test with one degree of freedom. Ordinal values were assigned to two categories of the MTR A2756G genotype and to three or four categories of dietary factors and genetic polymorphisms. An interaction term was then created by multiplying ordinal values for the MTR A2756G genotype by those for dietary factors or genetic polymorphisms. Two-sided P values < 0.05 were regarded as statistically significant. All statistical analyses were carried out using Statistical Analysis System (SAS), version 9.1 (SAS Institute).
Results
Characteristics of cases and controls are summarized in Table 1 . Despite the different selection scheme between men and women, sex distribution was reasonably similar between cases and controls. Due to male cases and controls not being frequency-matched in age categories, male cases were noted to be older than male controls. Ever smokers and family history of colorectal cancer were more frequent among cases than controls, whereas nonsteroidal anti-inflammatory drug use was more common among controls. Cases were found to have a higher body mass index than controls. Although the proportion of current drinkers was similar between cases and controls, the amount of alcohol intake was much higher among cases. Table 2 shows the association of MTR A2756G and selected polymorphisms (MTRR A66G, and MTHFR C677T and A1298C) with colorectal adenoma. Genotype frequencies among controls were in agreement with the Hardy-Weinberg equilibrium for all four polymorphisms examined. Overall, MTR A2756G was not measurably associated with colorectal adenoma. Sex-adjusted ORs for the AA, AG, and GG genotypes were 1.00 (reference), 1.08 (95% CI, 0.85-1.37), and 0.83 (95% CI, 0.46-1.50), respectively. Similarly to MTR A2756G, none of the selected polymorphisms were related to colorectal adenoma. We did not observe any interaction between any of the four polymorphisms examined and sex (data not shown). These results were not changed on further adjustment for potential confounders.
We also investigated the association between several dietary factors involved in the DNA methylation pathway (alcohol, folate, and vitamins B 2 , B 6 , and B 12 ) and colorectal adenoma (Table 3) . A significant trend across intake categories was observed only for alcohol consumption (P for trend = 0.003). Sex-adjusted OR of colorectal adenoma for heavy drinkers compared with never drinkers was significantly higher than unity (OR, 1.67; 95% CI, 1.14-2.44). However, further adjustment for potential confounders attenuated the association between alcohol consumption and colorectal adenoma, although the trend across intake categories remained significant (P for trend = 0.04). The other four nutrient intakes examined were not related to colorectal adenoma. Table 4 shows the interaction of MTR A2756G with several dietary factors in the risk of colorectal adenoma. The results were adjusted for potential confounders as well as sex and matching variables. A statistically significant interaction was evident only for alcohol consumption (P for interaction = 0.007), although the interaction with folate intake was marginally significant (P for interaction = 0.07). Compared with never drinkers with the MTR 2756 AA genotype, never drinkers with the AG or GG genotype exhibited a substantial decrease in OR of 0.56 for colorectal adenoma (95% CI, 0.34-0.90), whereas heavy drinkers with the AG or GG genotype showed a substantial increase in OR of 1.90 (95% CI, 1.04-3.46). Further, a significant trend across drinking categories was observed among those with the AG or GG genotype (P for trend = 0.002).
We further assessed whether the association between MTR A2756G and colorectal adenoma was modified by selected polymorphisms. The results are shown in Table 5 , with a statistically significant interaction for MTHFR C677T (P for interaction = 0.02). Compared with those homozygous for the major alleles of the two polymorphisms, those with the MTR 2756 AG or GG genotype and the MTHFR 677 CC genotype had an f1.5-fold increase in OR for colorectal adenoma (95% CI, 1.01-2.27).
Finally, we repeated the above analyses excluding those with the MTR 2756 GG genotype (n = 47) primarily on the basis that the AG and GG genotypes might differ in their influence on the enzymatic activity of methionine synthase. The results were essentially the same as those above (data not shown). A statistically significant interaction still remained for alcohol intake (P for interaction = 0.01) and MTHFR C677T (P for interaction = 0.01), whereas the marginal interaction for folate intake became significant (P for interaction = 0.03).
Discussion
Here, we hypothesized that individuals with the MTR 2756 AG or GG genotype would have a decreased risk of colorectal adenoma. However, the results showed no association of the polymorphism alone with colorectal adenoma. Our findings show some consistencies with those of all four previous studies on colorectal adenoma (4, (23) (24) (25) . *Sixty-eight past drinkers were not included in the analysis. Light (<150 g/wk), moderate (150-299 g/wk), and heavy (z300 g/wk). cAdjusted for sex, age, screening period, smoking status, BMI, family history of colorectal cancer, and NSAID use. Despite the lack of an overall association, we nevertheless observed a statistically significant interaction between MTR A2756G and alcohol intake, an established risk factor for colorectal neoplasm (38) . This finding is consistent with our hypothesis that the G allele afforded protection against colorectal adenoma, but only among never drinkers. The minor allele, on the other hand, conferred vulnerability to the deleterious effects of alcohol consumption, with the AG and GG genotypes associated with an f2-fold higher risk than the AA genotype among heavy drinkers. Significant effect modification by alcohol intake has also been identified in studies on not only colorectal adenoma (24) but also colorectal cancer (16, 20) .
Alcohol consumption has a hazardous effect on folate metabolism, which is closely related to the DNA methylation pathway. Alcohol drinking inhibits folate absorption from the intestine, interrupts folate release from the liver, and promotes urinary excretion of folate from the body (6), all of which result in reduced levels of serum folate (7), of which 5-methyl-tetrahydrofolate is the predominant component. The provision of 5-methyltetrahydrofolate is crucial for methionine synthase to catalyze the remethylation of homocysteine to methionine. In addition, alcohol intake can directly interfere with the enzymatic activity of methionine synthase (39) . Further, the influence of alcohol intake may vary among individuals with different genetic susceptibility. Our observation of an interaction between MTR A2756G and alcohol consumption suggests that the DNA methylation pathway is implicated in the development of colorectal adenoma.
In the present study, 24% of current drinkers consumed z300 grams of ethanol per week. The National Nutrition Survey in Japan has reported similar results, citing that the proportion of current drinkers z40 years old who drink z40 grams of ethanol per day is 23% (40) . The fact that a relatively high proportion of Japanese adults consume a large amount of alcohol on a regular basis might have led to our observation of an interaction between MTR A2756G and alcohol consumption.
Given that alcohol consumption interacts with MTR A2756G in part through its antagonistic effect on folate metabolism, a similar effect modification by folate consumption might also be anticipated. In fact, an interaction between MTR A2756G and folate intake was also exhibited in the present study, albeit with only marginal significance. Compared with those with the AA genotype, those with the AG or GG genotype showed an inverse association between folate consumption and the risk of colorectal adenoma. Among G allele carriers, however, only those in the highest tertile (z432 Ag/d of folate) had a decreased risk, implying that the G allele may require a considerably good folate status to confer protection against colorectal adenoma. In this regard, individuals in the highest tertile consumed at least 1.8-fold the recommended daily allowance of folate for Japanese adults (240 Ag/d; ref. 40) .
We also found that the association between MTR A2756G and colorectal adenoma was modified by MTHFR C677T. This finding, however, should be interpreted with caution: although not only MTHFR C677T but also MTHFR A1298C resulted in decreased enzymatic activity of MTHFR related to its minor allele (26, 27) , the observed effect modification differed considerably between the two polymorphisms, notwithstanding a previous study that showed a similar effect modification by MTHFR C677T (18) . Further studies are needed to confirm these findings.
Among the strengths of the present study, the provision of total colonoscopy to all study subjects would have decreased the likelihood of misclassification between cases and controls. The study was conducted in a Japanese population with a relatively homogenous genetic background, which likely obviated the possibility of population stratification. Finally, the number of subjects was larger than in previous studies on MTR A2756G and colorectal adenoma (4, (23) (24) (25) .
Control selection is a major concern in studies of genetic polymorphisms. In the present study, genotype frequencies were in agreement with the Hardy-Weinberg equilibrium and allele frequencies were reasonably similar to those previously reported in Japanese populations (17, 18, 20) . Another concern is information bias; there was no difference, however, in the availability of blood specimens between cases and controls participating in CAST. Further, MTR genotyping was complete in >99% of both cases and controls with available specimens. Finally, it is generally considered that confounding is less likely in genetic polymorphism studies thanks to the effect of ''Mendelian Randomization'' (41) . In fact, further adjustment for potential confounders did not change the association of MTR A2756G and the selected polymorphisms with colorectal adenoma.
One limitation of the study that warrants mention is the lack of quality control assessment of the genotyping determinations using the study samples, possibly resulting in some misclassification in genotyping status. Such misclassification would have been undifferentiated, however, as genotyping was carried out with researchers blinded to case-control status. Undifferentiated misclassification, if present, is likely to underestimate the true relative risk. Given that all four single nucleotide polymorphisms analyzed in this study passed our primary checks, any influence of genotyping misclassification on the present findings is likely to be minimal.
In conclusion, we observed that MTR A2756G interacted with alcohol and folate intake to influence the risk of colorectal adenoma. The G allele may confer protection against colorectal adenoma in the presence of a considerably good folate status. Our findings add to increasing evidence that DNA methylation plays an important role even at an early stage of colorectal carcinogenesis.
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